Join to view full profile
710 Westwood Plaza, C119 RNRCLos Angeles, CA 90095
Phone+1 310-825-7266
Fax+1 310-825-7266
Dr. Wiedau is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Martina Wiedau is a neurologist based in Los Angeles, specializing in neuromuscular medicine. She completed her education and training at the UCLA David Geffen School of Medicine, culminating in a neurology fellowship. Dr. Wiedau has held a long-standing role as a professor in the Department of Neurology at UCLA since 2003. Her expertise is in amyotrophic lateral sclerosis (ALS), with several publications focusing on ALS. She has been involved in clinical trials and research related to ALS treatment and holds CMS Meaningful Use certifications.
She serves as the Department of Neurology Medical Director and Vice Chair of Neurology for Clinical Affairs. She has been recognized as a Super Doctor by SuperDoctors.com.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neurology, 2000 - 2003- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1997 - 2000
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1996 - 1997
Philipps University of Marburg Faculty of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1998 - 2028
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- Super Doctor SuperDoctors.com
Clinical Trials
- Mexiletine for the Treatment of Muscle Cramps in ALS
- Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Start of enrollment: 2019 Oct 21
Publications & Presentations
PubMed
- Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the ...Namita A Goyal, Jinsy A Andrews, Björn E Oskarsson, Martina H Wiedau, Edward J Kasarskis
Biomedicines. 2025-12-12 - 1 citationsALSUntangled #77: Psilocybin.Bhavya Bakshi, Sandeep Yerraguntla, Carmel Armon, Paul Barkhaus, Tulio Bertorini
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-05-01 - ALSUntangled #74: Withania Somnifera (Ashwagandha).Sartaj Jhooty, Paul Barkhaus, Andrew Brown, Javier Mascias Cadavid, Gregory T Carter
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01
Press Mentions
UCLA ALS Clinic Becomes 100th Treatment Center of ExcellenceSeptember 22nd, 2025- The ALS Association Marks Milestone: 100th Certified Treatment Center of Excellence®September 18th, 2025
Grant Support
- MDAMDA2019–2023
- Project 2National Institute Of Neurological Disorders And Stroke2010–2012
- Gsk-3beta &Beta-Catenin In Pathophysiology Of FTDP-17National Institute Of Neurological Disorders And Stroke2004–2008
Professional Memberships
- Fellow
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
